Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort : determinants and consequences / Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group

GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more.

Saved in:
Persons: Lutter, Johanna I. [Author]; Jörres, Rudolf A. [Author]; Trudzinski, Franziska [Author]; Alter, Peter [Author]; Kellerer, Christina [Author]; Watz, Henrik [Author]; Welte, Tobias [Author]; Bals, Robert [Author]; Kauffmann-Guerrero, Diego [Author]; Behr, Jürgen [Author]; Holle, Rolf [Author]; Vogelmeier, Claus F. [Author]; Kahnert, Kathrin [Author]
Format: eArticle
Language(s):English
Publication:14 April 2021
Part of:The International journal of chronic obstructive pulmonary disease 16(2021), Seite 987-998
Notes:Gesehen am 18.05.2021
Physical description:12
ISSN:1178-2005
DOI:10.2147/COPD.S304532